相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The evaluation of safety and efficacy of colistin use in pediatric intensive care unit: Results from two reference hospitals and review of literature
Zumrut Sahbudak Bal et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2018)
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
Mical Paul et al.
LANCET INFECTIOUS DISEASES (2018)
Antimicrobial resistance among children in sub-Saharan Africa
Phoebe C. M. Williams et al.
LANCET INFECTIOUS DISEASES (2018)
Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study
Ritesh Aggarwal et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2018)
Past and Present Perspectives on β-Lactamases
Karen Bush
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant Gram-negative bacteria in Thailand
Thundon Ngamprasertchai et al.
INFECTION AND DRUG RESISTANCE (2018)
Acinetobacter Infections in Neonates
Raffaele Zarrilli et al.
CURRENT INFECTIOUS DISEASE REPORTS (2018)
Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
Oren Zusman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens
J. Dobias et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Infectious disease exposures and outbreaks at a South African neonatal unit with review of neonatal outbreak epidemiology in Africa
A. Dramowski et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
Latania K. Logan et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy
Bora Shin et al.
JOURNAL OF MICROBIOLOGY (2017)
Health-care-associated infections in neonates, children, and adolescents: an analysis of paediatric data from the European Centre for Disease Prevention and Control point-prevalence survey
Walter Zingg et al.
LANCET INFECTIOUS DISEASES (2017)
Late-onset Sepsis in Extremely Premature Infants 2000-2011
Rachel G. Greenberg et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)
Colistin use in critically ill neonates: A case-control study
Mehmet Sah Ipek et al.
PEDIATRICS AND NEONATOLOGY (2017)
Use of Colistin in a Neonatal Intensive Care Unit: A Cohort Study of 65 Patients
Eren Cagan et al.
MEDICAL SCIENCE MONITOR (2017)
Carbapenem-Resistant Enterobacteriaceae
Alina Lovleva et al.
CLINICS IN LABORATORY MEDICINE (2017)
Antimicrobial-resistant Gram-negative infections in neonates: burden of disease and challenges in treatment
Laura Folgori et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2017)
Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome
Yasemin Ozsurekci et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
Clinical considerations for optimal use of the polymyxins: A focus on agent selection and dosing
J. M. Pogue et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii
Thien B. Tran et al.
JOURNAL OF ANTIBIOTICS (2016)
Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B
Maria Helena Rigatto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Outbreak of NDM-1-producing Klebsiella pneumoniae ST76 and ST37 isolates in neonates
J. Zhu et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
An audit of colistin use in neonatal sepsis from a tertiary care centre of a resource-limited country
Bonny Jasani et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2016)
Epidemiology of infections caused by polymyxin-resistant pathogens
Helen Giamarellou
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
Thien B. Tran et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Extended spectrum beta-lactamase producing Enterobacteriaceae causing bloodstream infections in rural Ghana, 2007-2012
Daniel Eibach et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015
Haidong Wang et al.
LANCET (2016)
Harmonisation in study design and outcomes in paediatric antibiotic clinical trials: a systematic review
Laura Folgori et al.
LANCET INFECTIOUS DISEASES (2016)
Pharmacokinetics of Colistin Following a Single Dose of Intravenous Colistimethate Sodium in Critically Ill Neonates
Narongsak Nakwan et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
Epidemiological characteristics and antimicrobial susceptibility among carbapenem-resistant non-fermenting bacteria in Brazil
Vanessa Cordeiro Dias et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2016)
Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study
Lancet Global Health (2016)
COLISTIN: adult and paediatric guideline for South Africa, 2016
Quinten Labuschagne et al.
SOUTHERN AFRICAN JOURNAL OF INFECTIOUS DISEASES (2016)
High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update
Michelle Lowings et al.
BMC INFECTIOUS DISEASES (2015)
Safety and Efficacy of Intravenous Colistin in Neonates With Culture Proven Sepsis
Kadir Serafettin Tekgunduz et al.
IRANIAN JOURNAL OF PEDIATRICS (2015)
Neonatal nosocomial bloodstream infections at a referral hospital in a middle-income country: burden, pathogens, antimicrobial resistance and mortality
Angela Dramowski et al.
PAEDIATRICS AND INTERNATIONAL CHILD HEALTH (2015)
Late-onset neonatal sepsis: recent developments
Ying Dong et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2015)
Efficacy and Safety of Intravenous Colistin in Preterm Infants with Nosocomial Sepsis Caused by Acinetobacter baumannii
Serdar Alan et al.
AMERICAN JOURNAL OF PERINATOLOGY (2014)
In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy
Kady Phe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Multi-drug resistant gram negative infections and use of intravenous polymyxin B in critically ill children of developing country: retrospective cohort study
Naveed-ur-Rehman Siddiqui et al.
BMC INFECTIOUS DISEASES (2014)
Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium
Felipe F. Tuon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Risk Factors and Outcomes for Multidrug-Resistant Gram-Negative Bacteremia in the NICU
Ming-Horng Tsai et al.
PEDIATRICS (2014)
A Five-Year Experience of Carbapenem Resistance in Enterobacteriaceae Causing Neonatal Septicaemia: Predominance of NDM-1
Saswati Datta et al.
PLOS ONE (2014)
Combined Intravenous and Intraventricular Administration of Colistin Methanesulfonate in Critically Ill Patients with Central Nervous System Infection
Mairi Ziaka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
Ana M. Sandri et al.
CLINICAL INFECTIOUS DISEASES (2013)
Pharmacokinetics of Colistin in Cerebrospinal Fluid after Intraventricular Administration of Colistin Methanesulfonate
Roberto Imberti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
Lidia Dalfino et al.
CLINICAL INFECTIOUS DISEASES (2012)
Carbapenem-Resistant Enterobacteriaceae: An Emerging Problem in Children
Latania K. Logan
CLINICAL INFECTIOUS DISEASES (2012)
Colistin pharmacokinetics: the fog is lifting
W. Couet et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?
Phillip J. Bergen et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Control of an Acientobacter baumannii outbreak in a neonatal ICU without suspension of service: a devastating outbreak in Diyarbakir, Turkey
S. Hosoglu et al.
INFECTION (2012)
Intravenous Colistin Administration in Neonates
Mamta Jajoo et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Acinetobacter species meningitis in children: a case series from Karachi, Pakistan
Ali Faisal Saleem et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2011)
Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models
Rajesh V. Dudhani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity
Maura S. Oliveira et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
Anima Poudyal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa
VH Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Developmental pharmacology - Drug disposition, action, and therapy in infants and children
GL Kearns et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children
BJ Anderson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
分享论文
